Calcipotriol/ja: Difference between revisions

Calcipotriol/ja
Created page with "<!--Identifiers--> | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 112965-21-6 | PubChem = 5288783 | IUPHAR_ligand = 2778 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB02300 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 4450880 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 143NQ3779B | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG..."
Created page with "<!--Pharmacokinetic data--> | bioavailability = 5 to 6% | metabolism = Liver/ja | excretion = 胆道"
Tags: Mobile edit Mobile web edit
Line 66: Line 66:
}}
}}


<div lang="en" dir="ltr" class="mw-content-ltr">
<!-- Definition and medical uses -->
<!-- Definition and medical uses -->
'''Calcipotriol''', also known as '''calcipotriene''', is a synthetic [[derivative (chemistry)|derivative]] of [[calcitriol]], a form of [[vitamin D]].  It is used in the treatment of [[psoriasis]]. It is safe for long-term application in psoriatic skin conditions.
'''カルシポトリオール''''''Calcipotriol''')は、[[vitamin D/ja|ビタミンD]]の一種である[[calcitriol/ja|カルシトリオール]]の合成[[derivative (chemistry)/ja|誘導体]]である。 [[psoriasis/ja|乾癬]]の治療に用いられる。乾癬性皮膚疾患への長期投与は安全である。
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
<div lang="en" dir="ltr" class="mw-content-ltr">